S | [1,38] | B0Y209 | Afu5g01990 | BYS1 domain protein, putative | Increased expression after voriconazole exposure | 2 | 2 | 86 | 0.0393 | 10.53 |
R | [1] | B0XVT1 | Afu2g05635 | Putativeuncharacterized, hypotheticalprotein | 5 | 5 | 491 | 0.0037 | 1.46 | |
S | [1] | B0XT52 | Afu7g00610 | Putative uncharacterized, cupin domain protein | 3 | 1 | 113 | 0.0459 | 1.09 | |
S | [1] [42] | B0XWT8 | Afu3g12790 | Conserved glutamic acid-rich protein | Transcript up-regulated in conidia exposed to neutrophils | 1 | 1 | 51 | 0.0041 | 4.59 |
R | [1] | B0Y1N8 | Afu5g01420 | Putative uncharacterized protein (secreted protein) | 7 | 7 | 255 | 0.0008 | 1.99 | |
R | [1] | B0XWK2 | Afu3g12982 | Putative uncharacterized protein (extracellular serine rich protein) | 2 | 2 | 74 | 0.0009 | 1.94 | |
S | [1] | B0Y6P7 | Afu4g10610 | Uncharacterized protein (stress responsive a b barrel domain protein) | 4 | 4 | 126 | 0.0015 | 1351 | |
S | [8] | Q4WFD3 | Afu3g02600 | Uncharacterizedprotein (putrescine oxidase) | 2 | 1 | 79 | 0.0101 | 3.02 | |
R | [1] | B0YAV2 | Afu8g00630 | Putative, uncharacterized (f5 8 type c domain) protein | 9 | 9 | 816 | 0.0001 | 1.70 | |
S | [1] | B0YCY3 | Afu6g04690 | Putative characterized (conserved hypothetical) protein | 14 | 14 | 873 | 0.0027 | 1.09 | |
S | [8] | Q4WM72 | Afu6g10930 | Putative, extracellular protein (DNA-directed RNA polymerase activity) | 11 | 11 | 513 | 0.0238 | 1.69 | |
S | [1] | B0Y1Q6 | Afu5g12780 | Uncharacterized (Kelchrepeat) protein | 5 | 5 | 176 | 0.0133 | 8.79 | |
Other | ||||||||||
S | [1] | B0XQ18 | Afu1g08960 | cAMP-regulated phosphoprotein family protein igo1 | 1 | 1 | 52 | 0.0044 | 4.33 | |
S | [1] | B0XMN4 | Afu1g02980 | 6-phosphogluconolactonase | 2 | 2 | 107 | 0.0444 | 3.31 | |
S | [1] | B0XZJ8 | Afu3g15090 | adenosine deaminase family protein (secreted protein) | 18 | 17 | 1029 | 0.0006 | 1.23 | |
R | [1] | B0Y214 | Afu5g02040 | lipase (secretedprotein) | 6 | 6 | 290 | 0.0337 | 1.19 | |
S | [1] [43] [44] | B0Y2N1 | fleA | fucose-specific lectin FleA | One of the genes regulated by SrbA, which plays a role in ergosterol biosynthesis and mediates resistance to azole antifungals (fluconazole susceptibility, lower voriconazole MIC in SrbA null mutant) Strong hemagglutinin activity. This lectin may enhance attachment of fungal spores to mammalian cell membranes and contribute to the pathogenicity. | 5 | 2 | 220 | 0.0061 | Infinity |